VITRECTOMY FOR THE TREATMENT OF FULL-THICKNESS STAGE-3 OR STAGE-4 MACULAR HOLES - RESULTS OF A MULTICENTERED RANDOMIZED CLINICAL-TRIAL

Citation
Wr. Freeman et al., VITRECTOMY FOR THE TREATMENT OF FULL-THICKNESS STAGE-3 OR STAGE-4 MACULAR HOLES - RESULTS OF A MULTICENTERED RANDOMIZED CLINICAL-TRIAL, Archives of ophthalmology, 115(1), 1997, pp. 11-21
Citations number
26
Categorie Soggetti
Ophthalmology
Journal title
ISSN journal
00039950
Volume
115
Issue
1
Year of publication
1997
Pages
11 - 21
Database
ISI
SICI code
0003-9950(1997)115:1<11:VFTTOF>2.0.ZU;2-Q
Abstract
Objective: To prospectively assess the risks and benefits of vitrectom y surgery for eyes with stage 3 or 4 macular holes. Design: A multicen tered, controlled, randomized clinical trial. Setting: Community- and university-based ophthalmology clinics. Patients: One hundred twenty p atients (129 eyes) with stage 3 or 4 macular holes. Interventions: Sta ndardized macular hole surgery vs observation alone. Main Outcome Meas ures: Four measures of best-corrected visual function, standardized ph otographic evaluation of the extent of hole closure, evaluation of len s opacification, and determination of adverse events. Outcomes were de termined at 6 months after randomization. Results: Compared with obser vation alone, a significant benefit due to surgery was found in the ra te of hole closure (4% vs 69%, P<.001). After adjusting for baseline v isual acuity, hole duration, and maximum hole diameter, a significant benefit due to surgery was found in visual acuity for the Bailey-Lovie Word Reading (P=.02) and the Potential Acuity Meter (P<.01) tests; a marginally significant benefit due to surgery was found in visual acui ty for the Early Treatment Diabetic Retinopathy Study chart (P=.05). A lthough the proportion of eyes achieving a change in visual acuity of 2 or more lines on the Early Treatment Diabetic Retinopathy Study char t was significantly greater for the surgery group vs the observed grou p (11 [19%] of 59 eyes vs 3 [5%] of 58 eyes, adjusted P=.05), 20 (34%) of 59 eyes randomized to surgery had a loss in visual acuity of 1 or more lines. Compared with the observation group, eyes randomized to su rgery had higher nuclear sclerosis scores (2.4 vs 1.3, P<.001). Fourte en adverse events were noted in the surgery group; none were noted in the observed group. Conclusions: Some visual benefit of vitrectomy sur gery for macular holes exists, despite a notable incidence of adverse events. The large variability in visual acuity outcome in the surgical group may be because of complications or progressive cataract. A stud y of the long-term outcome after macular hole surgery is needed.